e-learning
resources
Milan 2017
Monday, 11.09.2017
PAH and CTEPH
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluation of a novel clinic for management of Chronic Thromboembolic Pulmonary Disease (CTED) and associated Pulmonary Hypertension (CTEPH).
A. Roddick (London, United Kingdom)
Source:
International Congress 2017 – PAH and CTEPH
Session:
PAH and CTEPH
Session type:
Thematic Poster
Number:
2406
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Roddick (London, United Kingdom). Evaluation of a novel clinic for management of Chronic Thromboembolic Pulmonary Disease (CTED) and associated Pulmonary Hypertension (CTEPH).. 2406
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Comparison of acute phase reactant pentraksin-3 and inflammatory parameters in acute and stable pulmonary embolism
Features of patients newly diagnosed pulmonary embolism during COVID pneumonia
CARDIAC DYSFUNCTION IN ACTIVE PULMONARY TUBERCULOSIS: DOUBLE TROUBLE!!
Related content which might interest you:
Incidence of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) at six months of a Pulmonary Embolism (PE). OSIRIS Study
Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism
Year: 2017
Global burden of chronic thromboembolic pulmonary hypertension (CTEPH): An epidemiological analysis
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014
Treatment of Chronic Thromboembolic Pulmonary Hypertension: A new approach
Source: International Congress 2018 – CC2 Broad spectrum of chronic thromboembolic pulmonary hypertension
Year: 2018
Epoprostenol dosing by concomitant therapies in the PROSPECT registry
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
Long-term data from the Swiss pulmonary hypertension registry
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
Frequency and risk factors for Chronic Thromboembolic Pulmonary Hypertension after a first unprovoked Pulmonary Embolism: results from PADIS-studies.
Source: Virtual Congress 2021 – Non-pulmonary arterial hypertension pulmonary hypertension
Year: 2021
Clinical efficacy of Macitentan in patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018
Venous thromboembolic disease (VTD) associated with inflammatory bowel disease (IBD): RIETE´s experience
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Examination about what determine quality of life (QOL) and the association between QOL and therapeutic intervention for patients with chronic thromboembolitic pulmonary hypertension (CTEPH)
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
HbA1c-levels in patients with operable chronic thromboembolic pulmonary hypertension
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014
Chronic Thromboembolic Pulmonary Hypertension related to ICD
Source: International Congress 2018 – CC2 Broad spectrum of chronic thromboembolic pulmonary hypertension
Year: 2018
Characteristics of patients with pulmonary hypertension in end stage renal disease
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
A retrospective study of depressive illness in patients with pulmonary hypertension (PH) at a specialist centre
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
Prognosis factors of recurrent pulmonary thromboembolism
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Sleep Disordered Breathing (SDB) and Chronic Thromboembolic Pulmonary Hypertension: the Effects of Pulmonary Endoarterectomy
Source: International Congress 2017 – CPAP therapy
Year: 2017
Exercise-induced pulmonary hypertension in patients with systemic sclerosis: Pilot-study
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
LATE-BREAKING ABSTRACT: Riociguat for the treatment of chronic thromboembolic pulmonary hypertension (CTEPH): 2-year results from the CHEST-2 long-term extension
Source: International Congress 2014 – New technologies and biomarkers in lung disease
Year: 2014
Rivaroxaban for treatment of venous thromboembolism. A real-life perspective in 103 patients
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Improving the safety of right heart catheterisation in sickle cell disease
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept